XL41 (R-454B) provides excellent performance and long term sustainability with a 78% reduction in GWP compared to R-410A
WILMINGTON, Del. , Oct. 16, 2018 /PRNewswire/ -- The Chemours Company (Chemours) ( CC ), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that its Opteon™ XL41 (R-454B) refrigerant, a low global warming potential (GWP) replacement for R-410A, has been selected by Johnson Controls for their YORK® YLAA scroll chiller platform in Europe , with capacity ranging from 190 to 530kW.
Opteon™ XL41 provides the industry with the lowest GWP solution to replace R-410A in positive displacement, direct expansion air-conditioning, heat pump, and chiller applications, without compromising performance. At a GWP of 466, Opteon™ XL41 reduces CO 2 emissions by 78% compared to R-410A, and more than a 30% reduction in CO 2 emissions when compared to R-32, another industry candidate to replace R-410A. This significant reduction in GWP without sacrificing capacity and improving energy efficiency by up to 5% over R-410A, comes at a critical time for the European industry, currently managing through regional F-Gas Regulations that phase down the use of HFCs.
Opteon™ XL41 was specifically designed to enable OEMs to quickly transition away from R-410A without requiring major equipment design modifications, yet achieve the maximum possible reduction in GWP to satisfy long-term regulatory requirements. "As a R-410A replacement, XL41 offers the optimal balance of performance, safety, sustainability & cost, and is a prime example of how our Opteon™ portfolio brings value to our customers and the market," said Diego Boeri , vice-president of Chemours Fluorochemicals. "It's great to see Johnson Controls continue to drive their strategy with a long-term, sustainable refrigerant choice for air cooled scroll chillers that can withstand the many CO 2 equivalent quota step-downs that are coming in the European Union F-gas Regulations."
Chemours is proud to offer a full portfolio of low GWP solutions to enable customers to meet their regulatory obligations and sustainability (both economic and environmental) goals. Opteon™ XL41 is part of a broad portfolio of Opteon™ refrigerant solutions for chillers, commercial refrigeration, air conditioning & heat pumps that allow the market to choose the optimal solution to meet their needs.
To learn more about Opteon™ XL41 (R-454B), visit Chemours' booth #7-222 at Chillventa, October 16-18 in Nuremberg Germany, or visit Opteon.com
About The Chemours Company
The Chemours Company ( CC ) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™. Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America , Latin America , Asia-Pacific and Europe.
This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance, business plans, prospects, targets, goals and commitments, capital investments and projects, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, and our outlook for net sales, Adjusted EBITDA, Adjusted EPS, Free Cash Flow, and Return on Invested Capital (ROIC), all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2017 . Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.
Sr. Global Marketing Communications Manager, Fluorochemicals
VP, Corporate Development and Investor Relations